Cyclerion Therapeutics (CYCN) Other Working Capital Changes (2018 - 2025)

Cyclerion Therapeutics (CYCN) posted quarterly Other Working Capital Changes of $52000.0 for Q1 2019.

Cyclerion Therapeutics (CYCN) Other Working Capital Changes (2018 - 2025) Analysis & Trends

Cyclerion Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$16000.0 for Q3 2025.

In Q3 2025, Other Working Capital Changes fell 108.94% year-over-year to -$16000.0; the TTM figure through Sep 2025 stood at -$179000.0 (down 212.58% YoY), while the FY2024 annual figure was $5000.0, up 103.12% from the prior year.
Other Working Capital Changes for Q1 2019 stood at $52000.0.
The five-year high for Other Working Capital Changes was $206000.0 in Q4 2021, with the low at -$774000.0 in Q1 2021.
The 5-year median for Other Working Capital Changes is -$16000.0 (2025), against an average of -$67000.0.
The sharpest annual moves came in 2021 and 2024: Other Working Capital Changes sank 8700.0% in 2021, then soared 677.42% in 2024.
Cyclerion Therapeutics' Other Working Capital Changes stood at $206000.0 in 2021, then plunged by 76.21% to $49000.0 in 2022, then plunged by 140.82% to -$20000.0 in 2023, then sank by 770.0% to -$174000.0 in 2024, then soared by 90.8% to -$16000.0 in 2025.
Business Quant data shows CYCN's Other Working Capital Changes at -$16000.0 in Q3 2025, $6000.0 in Q2 2025, and $5000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Cyclerion Therapeutics	12.71 Mn	9.47 Mn	-

Download Data